Thu 26 Nov 2009 | 12:49 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (LGND.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View LGND on other exchanges
As of  25 Nov 2009
2.02USD
Price Change
-0.11
Percent Change
-5.16%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 30 Dec 2008
Aryeh, Jason -- -- -- --
Berkman, Charles 244,010 -- 169,615 491,840
Burakoff, Steven -- -- -- --
Davis, Todd -- -- -- --
Higgins, John 418,333 -- 310,034 1,860,060
Kazmi, Syed -- -- -- --
Knott, David -- -- -- --
Kozarich, John -- -- -- --
Meglasson, Martin 316,207 -- 273,040 684,720
Sabba, Stephen -- -- -- --
Sharp, John 255,833 -- 155,037 499,865